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ABSTRACT 
Living with CKD is associated with hardships for patients and their care-partners. 
Empowering patients and care-partners may help minimize the burden and consequences of CKD 
related symptoms to enable life participation. There is a need to broaden the focus on living well with 
kidney disease and re-engagement in life. The World Kidney Day (WKD) Joint Steering Committee 
has declared 2021 the year of “Living Well with Kidney Disease” in an effort to increase education 
and awareness on the important goal of patient empowerment and life participation. This calls for the 
development and implementation of validated patient-reported outcome measures to address areas of 
life participation in routine care. It could be supported by regulatory agencies as a metric for quality 
care. Funding agencies could establish targeted calls for research that address the priorities of patients. 
Patients with kidney disease and their care-partners should feel supported to live well through 
concerted efforts by kidney care communities including during pandemics. In the overall wellness 
program for kidney disease patients, the need for prevention should be reiterated. WKD 2021 
continues to call for increased awareness of the importance of preventive measures throughout 
populations, professionals, and policy makers, applicable to both developed and developing countries.  
Keywords: 
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1. Patient Priorities for Living Well: a Focus on Life Participation
CKD, its associated symptoms, and its treatment, including medications, dietary and fluid 
restrictions, and kidney replacement therapy can disrupt and constrain daily living, and impair the 
overall quality of life of patients and their family members. Consequently, this can also impact 
treatment satisfaction and clinical outcomes.1 Despite this, the past several decades have seen limited 
improvement in the quality of life of people with CKD.1 To advance research, practice, and policy, 
there is increasing recognition of the need to identify and address patient priorities, values, and goals.1 
Several regional and global kidney health projects have addressed these important questions 
including the Standardised Outcomes in Nephrology (SONG) with more than 9,000 patients, family 
members, and health professionals from over 70 countries.2, 3 Across all treatment stages, including 
CKD, dialysis and transplantation, SONG participating children and adults with CKD consistently 
gave higher priority to symptoms and life impacts than health professionals.2, 3 In comparison, health 
professionals gave higher priority to mortality and hospitalization than patients and family members. 
The patient-prioritized outcomes are shown in Figure 1. Irrespective of the type of kidney disease or 
treatment stage, patients wanted to be able to live well, maintain their role and social functioning, 
protect some semblance of normality, and have a sense of control over their health and wellbeing. 
Life participation, defined as the ability to do meaningful activities of life including, but not 
limited to, work, study, family responsibilities, travel, sport, social, and recreational activities, was 
established a critically important outcome across all treatment stages of CKD.1, 2 The quotations from 
patients with kidney disease provided in Box 1 demonstrates how life participation reflects the ability 
to live well with CKD.4 According to the World Health Organization (WHO), participation refers to 
“involvement in a life situation.”5 This concept is more specific than the broader construct of quality 
of life.  Life participation places the life priorities and values of those affected by CKD and their 
family at the center of decision making. The World Kidney Day Steering Committee calls for the 
inclusion of life participation, a key focus in the care of patients with CKD, to achieve the ultimate 
goal of living well with kidney disease. This calls for the development and implementation of 
validated patient-reported outcome measures, that could be used to assess and address areas of life 
participation in routine care. Monitoring of life participation could be supported by regulatory 
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agencies could establish targeted calls for research that address the priorities of patients, including life 
participation.
2. Patient Empowerment, Partnership and a Paradigm Shift towards a Strengths-based 
Approach to Care
Patients with CKD and their family members including care-partners should be empowered to 
achieve the health outcomes and life goals that are meaningful and important to them. The WHO 
defines patient empowerment as “a process through which people gain greater control over decisions 
or actions affecting their health,”6 which requires patients to understand their role, to have knowledge 
to be able to engage with clinicians in shared decision-making, skills, and support for self-
management. For patients receiving dialysis, understanding the rationale for a lifestyle change, having 
access to practical assistance and family support promoted patient empowerment, while feeling 
limited in life participation undermined their sense of empowerment.7 
The World Kidney Day Steering Committee advocates for strengthened partnership with 
patients in the development, implementation, and evaluation of interventions for practice and policy 
settings, that enable patients to live well with kidney diseases. This needs to be supported by 
consistent, accessible, and meaningful communication. Meaningful involvement of patients and 
family members across the entire research process, from priority setting and planning the study 
through to dissemination and implementation, is now widely advocated.8 There have also been efforts, 
such as the Kidney Health Initiative, to involve patients in the development of drugs and devices to 
foster innovation.9 
We urge for greater emphasis on a strengths-based approach as outlined in Table 1, which 
encompasses strategies to support patient resilience, harness social connections, build patient 
awareness and knowledge, facilitate access to support, and establish confidence and control in self-
management. The strengths-based approach is in contrast to the medical model where chronic disease 
is traditionally focussed on pathology, problems, and failures.10 Instead, the strengths-based approach 
acknowledges that each individual has strengths and abilities to overcome the problems and 
challenges faced, and requires collaboration and cultivation of the patient’s hopes, aspirations, 
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in the health care system also need to be identified, so all patients are given the opportunity to have a 
voice.
3. The Role of Care-Partner 
A care-partner is often an informal caregiver who is also a family member of the patient with 
CKD.11 They may take on a wide range of responsibilities including coordinating care (including 
transportation to appointments), administration of treatment including medications, home dialysis 
assistance, and supporting dietary management. Caregivers of patients with CKD have reported 
depression, fatigue, isolation, and also burnout. The role of the care-partner has increasingly become 
more important in CKD care given the heightened complexity in communicative and therapeutic 
options including the expansion of telemedicine under the COVID-19 pandemic and given the goal to 
achieve higher life expectancy with CKD.12  The experience of caring for a partially incapacitated 
family member with progressive CKD can represent a substantial burden on the care-partner and may 
impact family dynamics.   Not infrequently, the career goals and other occupational and leisure 
aspects of the life of the care-partner are affected because of CKD care partnership, leading to care-
partner overload and burnout.  Hence, the above-mentioned principles of life participation need to 
equally apply to care-partners as well as all family members and friends involved in CKD care. 
4. Living with Kidney Disease in Low-Income Regions
In low and lower-middle-income countries (LICs and LMICs) including in sub-Saharan 
Africa, South East Asia, and Latin America, patient’s ability to self-manage or cope with the chronic 
disease vary but may often be influenced by internal factors including spirituality, belief system, and 
religiosity, and external factors including appropriate knowledge of the disease, poverty, family 
support system, and one’s grit and social relations network. The support system comprising healthcare 
providers and caregivers plays a crucial role as most patients rely on them in making decisions, and 
for the necessary adjustments in their health behavior.13  In LIC regions, where there are often a 
relatively low number of physicians and even lower number of kidney care providers per population 
especially in rural areas, a stepwise approach can involve local and national stakeholders including 
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education in rural areas, 2) adapting telehealth technologies if feasible to educate patients and train 
local community kidney care providers and 3) implementing effective retention strategies for rural 
kidney health providers including adapting career plans and competitive incentives.
Many patients in low resource settings present in very late stage needing to commence 
emergency dialysis.14 The very few fortunate ones to receive kidney transplantation may acquire an 
indescribable chance to normal life again, notwithstanding the high costs of immunosuppressive 
medications in some countries.  For some patients and care-partners in low-income regions, 
spirituality and religiosity may engender hope, when ill they are energized by the anticipation of 
restored health and spiritual wellbeing. For many patients, informing them of a diagnosis of kidney 
disease is a harrowing experience both for the patient (and caregivers) and the healthcare professional. 
Most patients present to kidney physicians (usually known as “renal physicians” in many of these 
countries) with trepidations and apprehension. It is rewarding therefore to see the patient’s anxiety 
dissipate after reassuring him or her of a diagnosis of simple kidney cysts, urinary tract infection, 
simple kidney stones, solitary kidneys, etc., that would not require extreme measures like kidney 
replacement therapy. Patients diagnosed with glomerulonephritis who have an appropriate 
characterization of their disease from kidney biopsies and histology; who receive appropriate 
therapies and achieve remission are relieved and are very grateful. Patients are glad to discontinue 
dialysis following resolution of AKI or acute on CKD.
Many CKD patients who have residual kidney function appreciate being maintained in a 
relatively healthy state with conservative measures, without dialysis. They experience renewed energy 
when their anemia is promptly corrected using erythropoiesis-stimulating agents. They are happy 
when their peripheral oedema resolves with treatment. For those on maintenance hemodialysis who 
had woeful stories from emergency femoral cannulations, they appreciate the construction of good 
temporary or permanent vascular accesses. Many patients in low resource settings present in very late 
stage needing to commence emergency dialysis. Patients remain grateful for waking from a uremic 
coma or recovering from recurrent seizures when they commence dialysis. 
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World Kidney Day 2021 theme on ‘Living Well with Kidney Disease’ is deliberately chosen 
to have the goals to redirect more focus on plans and actions towards achieving patient-centred 
wellness.  “Kidney Health for Everyone, Everywhere” with emphasis on patient-centred wellness 
should be a policy imperative that can be successfully achieved if policy makers, nephrologists, health 
care professionals, patients, and care partners place this within the context of comprehensive care. 
The requirement of patient engagement is needed. World Health Organization (WHO) in 2016 put out 
an important document on patient empowerment (WHO 2016): ‘Patient engagement is increasingly 
recognized as an integral part of health care and a critical component of safe people-centred services. 
Engaged patients are better able to make informed decisions about their care options. In addition, 
resources may be better used if they are aligned with patients’ priorities and this is critical for the 
sustainability of health systems worldwide. Patient engagement may also promote mutual 
accountability and understanding between patients and health care providers. Informed patients are 
more likely to feel confident to report both positive and negative experiences and have increased 
concordance with mutually agreed care management plans. This not only improves health outcomes 
but also advances learning and improvement while reducing adverse events.’ In the ISN Community 
Film Event at World Congress of Nephrology (WCN) 20 (ISN Community Film Event 2020), it is 
good to see a quote in the film from patients: “Tell me. I will forget; Show me. I will remember; 
Involve me. I will understand.” ISN Global Kidney Policy Forum 2019 included a patient speaker 
Nicki Scholes-Robertson from New Zealand: ‘Culturally appropriate and sensitive patient information 
and care are being undertaken in New Zealand to fight inequities in kidney health, especially in Maori 
and other disadvantaged communities.’
World Kidney Day 2021 would like to promote to the policy makers on increasing focus and 
resources on both drug and non-drug programmes in improving patient wellness. Examples include 
funding for erythropoiesis-stimulating agents and anti-pruritic agents for managing anemia and 
itchiness respectively, just name but a few.15, 16 Home dialysis therapies have been consistently found 
to improve patient autonomy and flexibility, quality of life in a cost-effective manner, enhancing life 
participation.  Promoting home dialysis therapies should tie in with appropriate ‘assisted dialysis’ 
programs to reduce patient and care partner fatigue and burnout. Also, examples like self-
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depression, anxiety, and insomnia should be promoted before resorting to medications.17 The 
principle of equity recognizes that different people with different levels of disadvantage require 
different approaches and resources to achieve equitable health outcomes. The kidney community 
should push for adapted care guidelines for vulnerable and disadvantaged populations.  The 
involvement of primary care and general physicians especially in LICs and LMICs would be useful in 
improving the affordability and access to services through the public sector in helping the symptom 
management of CKD patients and improve their wellness. In the overall wellness program for kidney 
disease patients, the need for prevention should be reiterated. Early detection with a prolonged course 
of wellness despite kidney disease, after an effective secondary prevention program, should be 
promoted.18 Prevention of CKD progression can be attempted by lifestyle and diet modifications such 
as a plant-dominant low protein diet and by means of effective pharmacotherapy including 
administration of sodium-glucose transport protein 2 (SGLT2) inhibitors.19  WKD 2021 continues to 
call for increased awareness of the importance of preventive measures throughout populations, 
professionals, and policy makers, applicable to both developed and developing countries.18
6. Conclusions
Effective strategies to empower patients and their care-partners strive to pursue the 
overarching goal of minimizing the burden of CKD related symptoms in order to enhance patient 
satisfaction, health-related quality of life, and life participation. World Kidney Day 2021 theme on 
‘Living Well with Kidney Disease” is deliberately chosen to have the goals to redirect more focus on 
plans and actions towards achieving patient-centered wellness. Notwithstanding the COVID-19 
pandemic that had overshadowed many activities in 2020 and beyond, the World Kidney Day 
Steering Committee has declared 2021 the year of “Living well with Kidney Disease” in an effort to 
increase education and awareness on the important goal of effective symptom management and 
patient empowerment.  Whereas the World Kidney Day continues to emphasize the importance of 
effective measures to prevent kidney disease and its progression,18 patients with preexisting kidney 
disease and their care-partners should feel supported to live well through concerted efforts by kidney 
care communities and other stakeholders throughout the world even during a world-shattering 
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uncompromisable goal of all kidney foundations, patient groups, and professional societies alike, to 
which the International Society of Nephrology and the International Federation of Kidney Foundation 
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Figure 1. Conceptual framework of “Living Well with Kidney Disease” based on patient 
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Table 1. Suggested strategies for “living well with CKD” using a strengths-based approach 
Strengths-based approach Suggested strategies
Build resilience  Identify or provide strategies and resources to manage stress and
functioning when encountering challenges, adversity and trauma
(e.g. commencement of dialysis)
Harness social connections  Facilitate connections with other patients to learn coping
strategies and for support
 Support family members/caregivers
Build awareness and 
knowledge
 Provide education (including practical advice) on diet and
lifestyle modifications
 Understand, identify, and address the potential impacts of CKD
(e.g. cognitive function).
 Encourage patients to ask questions.
 Encourage the use of knowledge to empower and prepare for the
future.
Facilitate access to support  Refer to allied health care professionals (e.g. dietitian, social
worker, mental health professionals, occupation therapists)
 Provide support that enables the patient to participate in
important life activities e.g. work.
Establish confidence and 
control in self-management
 Support informed and shared decision-making (including
dialysis, kidney transplantation, conservative or non-dialytic
care)
 Encourage patients to learn to “get in tune” with what works
well for them and to voice any concerns, and work together to
develop better management strategies to enable patients to feel
better.
 Provide strategies to prevent or manage complications (e.g.
infection)










Abbreviations: CKD: chronic kidney disease (not receiving kidney replacement therapy)
This article is protected by copyright. All rights reserved
Box 1.  Quotations from patients with CKD related to priorities for living well
“I don’t want to think about dying from my disease. I want to be able to live well with my disease.” – Patient with 
CKD
“Life participation is most important because without it, you can’t do anything.” – Child with CKD
“Maybe it’s as simple as asking patients whether, how well they are able to participate in the life that they want 
to lead because it’s going to be different for different people” – Kidney transplant recipient
“Everyone has to face death, what I would like to have is a good quality of life rather than to face death.” – 
Kidney transplant recipient
“So, it doesn't actually really matter what the numbers say, and some of my numbers should have suggested that I 
should be feeling a lot worse than what I actually was, it's about how much I feel I can do and participate in my 
life and feel normal.” – Patient with CKD
“I’m still living. I get out of bed, and I’m still living and still breathing. As long as I can do that, I’m going to 
carry on and be positive because life is short.” Patient with CKD
“I put life participation because I know that looking from the outside, I know [his kidney disease] stops [him] 
from thinking bigger. . .Although that’s really big, there’s this life that has to happen at the same time.” – Family 
member
“Amazed at comments from professional(sic) about travel, free time, etc they seem to think the mechanics of 
dialysis far more important. Dialysis is a treatment which keeps us alive to live a life, not just to wait for death. – 
Patient receiving dialysis
“I prefer to be above ground, then below ground. So why not enjoy life whilst being above ground.” Adam 
Martin
“Over the years, I have learned to worry less, control my emotions, and not fear death. I keep my mind active. I 
follow the advice of the philosopher-emperor Marcus Aurelius to 'love the hand that fate (has dealt me) and play 
it as (my) own'. Living well with CKD means to live the best life I can in the time I have available….Living well 
with CKD is the same as living well.” – Tess Harris
“While CKD brings me some limitations, I can maximize the possibility to live well. I kept working when I was 
doing hemodialysis. After transplant, I could live: study, work, travel, marry, have children, and service the 
community.” – Maggie Ng
*Personal communication; quotations are identified by name with permission
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